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Abstract 
 
Background: Panic disorder with agoraphobia (PDA) co-occurs highly with depression. 
Greater panic symptoms, agoraphobic avoidance, comorbidity and anxiety sensitivity 
have all been linked to depressive symptoms in PDA. Psychotherapy research has 
historically linked prognostic and process expectationsto symptom severity. However, no 
study has explored the relationship of expectancies and depressive symptoms in PDA. 
The purpose of the present study was to determine the extent to which expectations 
and panic symptomatology have a differential impact on depressive symptoms in PDA 
above and beyond the influence of anxiety sensitivity and secondary Axis I comorbid 
disorders (e.g., generalized anxiety disorder, social anxiety disorder) just prior to entering 
therapy. Method: The relationship between depressive symptoms, panic 
symptomatology and expectancies (i.e., prognostic and process expectations) was 
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investigated in 74 patients with a primary diagnosis of panic disorder with agoraphobia. 
It was hypothesized that expectancy measures rather that panic symptomatology 
would add to the prediction of depressive symptoms beyond the effects of secondary 
comorbid disorders and anxiety sensitivity. Results: The findings showed that prognostic 
and process expectations accounted for significant variance in depressive symptoms 
beyond that predicted by anxiety sensitivity and secondary Axis I comorbid disorders. In 
addition, PDA symptomatology failed to significantly enter into our prediction model. 
Conclusions: These results suggest that expectancies have a greater impact on 
depressive symptoms in PDA regardless of the secondary comorbid disorders and 
severity of symptoms in PDA. Implications of these findings on the treatment of PDA are 
discussed. 
 
Key words: prognostic expectations, process expectations, anxiety expectancy, anxiety 
sensitivity, panic disorder with agoraphobia, depression. 
 
Introduction 
 
Panic disorder is frequently accompanied by agoraphobia (American Psychological 
Association, 1994). Panic disorder is a sudden onset of intense apprehension or doom 
associated with four out of thirteen symptoms such as shortness of breath, 
palpitations, chest pain or discomfort, choking or smothering sensations, and fear of 
“going crazy” or losing control (American Psychiatric Association, 1994). 
Agoraphobia is a fear about being in places or situations from which escape might 
be difficult (or embarrassing) or in which help may not be available in the event of 
having a panic attack (American Psychiatric Association, 1994).  The co-occurrence 
of panic disorder with agoraphobia (PDA) and depression has been demonstrated 
in numerous studies (Andrade, Eaton, & Chilcoat, 1994; Regier, Rae, Narrow, Kaelber 
& Schazberg, 1998; Renneberg, Chambless, & Gracely, 1992; Tsao, Lewin, & Craske, 
1998). For instance, Renneberg and colleagues (1992) reported that 15% of the PDA 
participants in their study suffered from major depression and 27% from dysthymia(a 
chronic depression that is less severe than major depressive disorder) (American 
Psychiatric Association, 1994). Higher levels of depressive symptoms may also be 
related to avoidance behaviour in anxiety disorders (Cassano, Perugi, Musetti, & 
Akiskal, 1989; Cox, Endler, & Swinson, 1995; Parker, Wilhelm, Mitchell, Austin, Roussos, 
& Gladstone, 1999; Telch, Brouillard, Telch, Agras, and Taylor, 1989). Telch and 
associates (1989) found that subjects with PDA had significantly greater levels of 
depression as measured by the Beck Depression Inventory (BDI; Beck, Steer, & Brown 
1996) than those with just panic disorder. Chambless (1985) also reported significant 
links between BDI scores and patients suffering from agoraphobia. Avoidance 
behaviours may also act as risk factors in the onset of depression. For instance, Parker 
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and colleagues (1999) found that social avoidance tends to precede the onset of 
major depression. In addition, Regier and colleagues (1998) discovered that the 
average age of onset of agoraphobia and comorbid depression is much younger 
for agoraphobia (i.e., 15.7 years old) than the age of onset for major depression (i.e., 
24.1 years old). This suggests that avoidance behaviours in PDA may precede and 
precipitate the onset of a comorbid major depressive episode.  
 
A stronger association has also been detected between anxiety expectancy (i.e., 
the extent to which patients expect to experience anxiety) and avoidance 
behaviour, rather than with the occurrence of panic attacks and avoidance (e.g., 
Cox, Endler and Swinson, 1995; Cox, Swinson, Norton and Kuch,1991; Craske, Rapee, 
& Barlow, 1988; Telch, et al., 1989; Whittal & Goetsch, 1997). For instance, Telch and 
colleagues (1989) found that panic expectancy was the best predictor of 
agoraphobic avoidance in PDA. Moreover, in contrast to panic disorder without 
agoraphobia, PDA patients reported more anticipation of panic. This implies that as 
expectation of panic increases, so does avoidance. This finding is also supported by 
Craske and Barlow’s (1988) hypothesis suggesting that there is a greater relationship 
between avoidance behaviour and anxiety expectancy rather than with the 
occurrence of panic attacks. Similarly, depressive symptoms in PDA patients are also 
considered predictors of panic expectancy. For instance, Whittal and Goetsch 
(1997) found that higher scores on the BDI predicted higher expectations of panic 
prior to entering a grocery store.  
 
Similar to the research results on anxiety expectancy, other studies have also 
demonstrated a relationship between high levels of anxiety sensitivity and 
avoidance behaviour. More specifically, individuals with high anxiety sensitivity 
expect that their anxiety sensations will cause them somatic, psychological or social 
harm (Reiss, 1991; Reiss, Peterson, Gursky & McNally, 1986). This suggests that 
negative expectations related to sensations of anxiety in panic disorder may lead to 
greater avoidance. According to Reiss’ expectancy theory (Reiss, 1991; Reiss et al., 
1986), anxiety sensitivity can precede panic attacks and may be a risk factor for 
panic disorder with agoraphobia (Reiss, 1991;Reiss et al., 1986; Maller & Reiss,1992). 
Once again, studies have also linked depression to greater fear of anxiety sensations 
(Taylor, Koch, Woody,& McLean, 1996). Taylor and associates (1996) detected high 
levels of anxiety sensitivity in individuals with depression. Schmidt, Lerew and Joiner 
(1998) found that high scores on the Anxiety Sensitivity Index (ASI; Reiss et al., 1986) 
were more likely to exacerbate depressive symptoms in the context of anxiety. Cox, 
Enns, Freeman and Walker (2001) demonstrated that patients who were no longer 
diagnosed with a major depressive episode after a one year follow-up, continued to 
score high on the ASI. In contrast to normal controls, formerly depressed patients 
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displayed significantly higher levels of anxiety sensitivity even though there was no 
difference between the two groups on level of depressed mood. 
 
The above studies on anxiety expectancy and anxiety sensitivity suggest a cognitive 
style that may be different in patients suffering from PDA alone versus those with PDA 
and high symptoms of depression. Since depression has been previously linked with 
negative automatic thinking, including pessimistic cognitions (Nekanda-Trepka, 
Bishop, & Blackburn, 1983; see Telch, 1988), low self-esteem, negative self-concepts 
and expectations (Bachelor, Bleau, & Raymond, 1996; Nekanda-Trepka et al., 1983), 
it would be important to examine to what extent overall expectations and panic 
symptomatology impact on PDA clients with depressive symptoms. By identifying 
these predictors, the treatment may be appropriately adapted to also meet the 
needs of those with PDA and comorbid depression. 
 
Studies have found evidence on the effects of panic symptomatology, anxiety 
expectancy and sensitivity on depressive symptoms in PDA. However, no studies to 
our knowledge, have examined the role of process expectations on depressive 
symptoms in PDA. Process expectations include (1) participant roles referring to 
anticipations regarding therapist characteristics, and therapist and client behaviour 
and attitudes expected to be displayed throughout therapy, and (2) anticipations 
referring to therapeutic process and procedures.  The negative cognitive style in 
depressive clients may also impact on their expectations of what therapy will involve. 
 
The majority of the studies conducted on process expectations are found in 
counselling research (e.g., Kunkel, Hector, Gongóra Coronado & Castillo Vales, 1989; 
Mezydlo Subich & Coursol, 1985; Tinsley, Bowman, & Ray, 1988; Tinsley, Brown, St. 
Aubin, & Lucek, 1984; Tinsley, Workman & Kass, 1980). Al-Darmaki and Kivlighan 
(1993) examined the effect of expectation congruence on the client-counsellor 
relationship and on their working alliance. The findings suggested that increased 
congruence in their expectations with regards to the therapeutic relationship is a 
good predictor of alliance. Examining the level of congruence in clients’ process 
expectations to the treatment they are about to participate in, may provide 
information on how to modify the treatment to address their needs or their 
incongruent expectancies at the beginning of therapy. 
 
This study examines the differential impact of panic symptomatology and 
expectancy on depressive symptoms in PDA. The association between depressive 
symptoms, panic symptomatology, prognostic expectancies (anxiety sensitivity, 
anxiety expectancy and avoidance expectancy), and process expectations was 
explored. Next, the differential impact of panic symptomatology and expectancies 
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on depressive symptoms was examined above and beyond the influence of 
secondary Axis I disorders (including depression) and anxiety sensitivity as measured 
by the ASI (Reiss et al., 1986). As previously indicated, the ASI has already been 
detected as a determinant of depression in several studies. We hypothesized that 
expectancy measures rather that panic symptomatology would add to the 
prediction of depressive symptoms beyond the effects of secondary comorbid 
disorders and anxiety sensitivity. 
 
Method 
 
Participants 
The sample consisted of 76 participants (26 males, 50 females) with a principal DSM-
IV (American Psychiatric Association, 1994) diagnosis of panic disorder with 
agoraphobia (PDA). The mean age of the sample was 40.1 years (SD = 10.11; range: 
19 - 65) and the mean education level was 11.9 years (SD = 3.46). The average 
number of years of marriage or cohabitation was 11.39 years (SD = 10.99). 
Approximately 39.5% of the patients were married, 38.2% were cohabiting, 17.1% 
were single, 2.6% were separated or divorced and 2.6% were widowed. Most 
participants (68.4%) took psychotropic medication. 
 
Participants were recruited from two specialized outpatient anxiety disorder clinics in 
Montreal: the Douglas Anxiety Clinic (n = 13) and the outpatient clinic at Louis-H. 
Lafontaine Hospital (n = 16). Participants were also recruited from advertisements in 
the local newspapers (n=47). Analyses of variance demonstrated no significant 
difference between clients referred from either of the two clinics and those referred 
from the local newspapers on any sociodemographic, expectancy, or symptom 
measure (p > .05). 
 
Patients included in the study met the following criteria: (a) a primary DSM-IV 
diagnosis of PDA assigned by a psychiatrist; (b) a primary diagnosis of PDA 
according to the Anxiety Disorders Interview Schedule, for DSM-IV, Lifetime Version 
(ADIS-IV-L; DiNardo et al., 1994) with a clinical severity rating of 4 or above on a scale 
ranging from 0 (none) to 8 (very severely disturbing-disabling), (c) a secondary DSM-
IV axis I diagnosis with an assigned ADIS-IV-L clinical severity rating which ranges from 
moderate to severely disabling (i.e., 4 to 6) and consists of a rating of 2 or more levels 
lower than the PDA rating, (d) age between 18 and 65 years, and (e) a mean of at 
least 1 panic attack per week in the 3 weeks prior to participating in the assessment. 
Exclusion criteria included: (a) the presence of substance-related, psychotic, and 
any organic brain conditions; and (b) the presence of any unstable medical 
condition considered by the evaluating psychiatrist to be mistaken for anxiety 
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symptoms (e.g., thyroid disorders, asthma, cardiovascular diseases, etc). The 
average duration of PDA was 12.8 years (SD = 9.8; range: 1 - 40 years). Patients met 
criteria for one or more of the following secondary diagnosis: generalized anxiety 
disorder (n = 20), major depressive disorder (n = 10), social phobia (n = 6), dysthymia 
(n = 4), obsessive compulsive disorder (n = 4), specific phobia (n = 4), post traumatic 
stress disorder (n = 4), hypochondriasis (n = 3), and mania (n = 1). 
 
Procedure 
Participants recruited from advertisements in the local newspapers were screened 
using a brief telephone interview in order to determine suitability. Potential 
candidates were invited to either one of the clinics to take part in the ADIS-IV-L 
administered by advanced graduate students in psychology. If the criteria for a 
primary diagnosis of PDA were satisfied according to the ADIS-IV-L, a psychiatrist 
subsequently evaluated the participants to confirm the initial diagnosis. Participants 
completed the questionnaire battery after their diagnosis had been confirmed. 
Those recruited directly from the clinics had already received a diagnosis of PDA by 
one of the psychiatrists. They nevertheless received the structured interview with the 
ADIS-IV-L in order to rule out an additional Axis I primary diagnosis and to confirm the 
psychiatrist's diagnosis. All participants provided informed consent prior to the 
structured interview with the ADIS-IV-L. No discrepancies were reported between the 
ADIS-IV-L diagnosis and that of the psychiatrist. 
 
Measures 
 
Symptom severity measures. Participants completed a battery of self-reported 
measures commonly used in PDA research. The following measures on symptom 
severity have demonstrated acceptable psychometric properties. A French 
validated version of these questionnaires was utilized in the current study. 
 
The ADIS-IV-L (DiNardo et al., 1994), a structured interview, was administered to 
assess the differential diagnoses among anxiety disorder categories. It also 
evaluated the history of the problem, situational and cognitive factors influencing 
anxiety, detailed symptom ratings and the interviewer's judgment of the degree of 
distress and interference in functioning associated with a PDA diagnosis. 
 
A validated French version of the Beck Depression Inventory-II (BDI-II; Beck et al., 
1996) was administered in the current study to assess the severity of depression over 
the last two weeks. It is composed of 21 items measuring depressive symptoms on a 
4-point scale. The BDI assesses somatic symptoms, mood disturbances and negative 
cognitions over the past two weeks. Sound psychometric properties have been 
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associated with the English version of this measure. In the current study, internal 
consistency was estimated at .91. There is no validation study for the French-
Canadian version of the BDI-II that was translated in 1997. The earlier French-
Canadian versions, the BDI (1961) and BDI 1A (1978), have been validated (Gauthier 
et al., 1982; Bourque and Beaudette, 1982). We nevertheless chose to administer the 
French-Canadian version of BDI-II because it is more consistent with the DSM-IV 
criteria for major depressive disorder than the earlier versions.  
 
The Body Sensations Questionnaire (BSQ; Chambless et al., 1984) and Agoraphobia 
Cognitions Questionnaire (ACQ; Chambless et al., 1984) assessed severity of 
cognitive panic symptoms. The BSQ is a 17-item questionnaire that measures level of 
fear concerning bodily sensations during a panic attack. The ACQ consists of 14 
items measuring the frequency of catastrophic thoughts during a panic attack. Both 
measures are rated on a 5-point Likert-type scale. Coefficient alpha for the BSQ in 
this study was estimated at .88 and for the ACQ at .77. The psychometric properties 
of the French-Canadian versions employed in this study are equivalent to those of 
the English version (Stephenson et al., 1998; Stephenson et al., 1999). 
 
The Mobility Inventory for Agoraphobia-Alone (MIA-A; Chambless et al., 1985) was 
used to assess the severity of agoraphobic avoidance behavior when the person is 
alone. This 26-item questionnaire is rated on a 5-point Likert-type scale. This study 
calculated the coefficient alpha at .92. Psychometric properties of the French-
Canadian version have been found to be similar to those of the English version 
(Stephenson et al., 1997). 
 
Beck Anxiety Inventory (BAI; Beck et al., 1988) assessed physical and cognitive 
symptoms experienced during the past week.  This 21-item questionnaire, rated on a 
4-point scale, examines the degree to which participants were affected by their 
symptoms over the past week. In this study, internal consistency was estimated at 
.93. Cronbach’s alpha of the French-Canadian version administered in this study has 
been previously calculated at .85 (Freestone, Ladouceur, Thibodeau, Gagnon, 
Rhéaume, 1994).   
 
Expectancy measures. All expectancy measures for this study were translated into 
French by the back-translation method (Vallerand, 1989; see Table 1 for overall 
distribution of all expectancy measures). 
 
Anxiety expectancies: The section on the severity of panic symptoms from the ADIS-
IV-L (Dinardo et al., 1994) was adapted and reformulated into expectations to assess 
prognostic expectations specifically related to panic-related symptoms. The 
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Symptom Expectancy Questionnaire (SEQ) consists of 14 items, rated on a 4-point 
scale, that measure the extent to which patients expect various panic-related 
symptoms to be diminished following therapy (e.g., At the end of treatment, I expect 
my symptoms of dizziness to....) The Cronbach alpha coefficient for the French 
version of the SEQ (Marcaurelle and Katerelos, 1998) using the current sample was 
calculated at .92. 
 
Avoidance expectancies: An adaptation of the Mobility Inventory for Agoraphobia-
Alone (MIA-A; Chambless et al., 1985) was used to assess prognostic expectations 
related to the degree to which clients expect their avoidance behavior to persist 
following therapy (i.e., avoidance expectancy). The same items were administered 
along with the corresponding 5-point scale. However, the adapted version contains 
questions reformulated into expectancies (e.g., "After the treatment, I expect to 
never avoid going to the movies"). With the current French sample and with the 
items reformulated into expectancies, internal consistency was at .92. This 
questionnaire will be referred to as the Expectancy Mobility Inventory for 
Agoraphobia-Alone (EMIA-A; Katerelos et al., 1998). 
 
Process expectations: The Process Expectations Questionnaire (PEQ; i.e., 
expectations of therapeutic process and procedures and roles of participants and 
therapist) was devised by the authors and consists of 28 items rated on a 4-point 
Likert scale (1= strongly agree to 4=strongly disagree) divided into two sub-scales, (1) 
expectations on the process and procedures of therapy (10 items); (2) role 
expectations (18 items). Nine out of the ten items on expectations on the process 
and procedures of therapy were inspired from the Attitudes Towards, and Beliefs 
about Psychotherapy Questionnaire (ABPQ; Furham and Wardley, 1990), a 40-item 
questionnaire, with an internal consistency of .70.  Items from this questionnaire that 
were adapted and reformulated into expectations include: 2 items loading highest 
on the factor conflicts and emotions referring to psychodynamic therapy (PDT) 
techniques; 4 items related to the factor dealing with what psychotherapy teaches 
or instructs clients (2 CBT items and 2 PDT); and 1 item referring to the background of 
psychotherapy sessions themselves (PDT item). The following items that did not load 
on any factor structures were also included because they were considered relevant 
to the current study: 1 question referring to exposure to a feared situation (CBT); and 
1 item pertaining to the unconscious nature of psychological problems (PDT). Finally, 
we also added 1 item examining whether clients expected to participate in 
exercises that would provoke anxiety symptoms (CBT), for a total of 10 items on the 
process and procedure expectancies. 
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The 18 items pertaining to role expectations were inspired from Thoughts about 
Psychotherapy Survey (TAPS; Kushner and Sher, 1989), the Reactions to 
Psychotherapy Questionnaire (RPQ; Furham and Wardley, 1990), Psychotherapy 
Questionnaire (PQ; Zwick and Attkisson, 1984) and the ABPQ, (Furham and Wardley, 
1990). Five of the 6 items from the TAPS were adapted and reformulated into 
expectations from the first of three factors entitled therapist competence and 
professionalism, and one item was inspired from therapist responsiveness and image 
concerns.  The 6 items adapted and reformulated into expectations from the RPQ 
include: 3 items loading highest on the factor negative reactions; 2 items associated 
with understanding; and 1 item loading on active change (i.e., involvement of 
patient in therapy). Four items were adapted and reformulated into expectations 
from the PQ: talking with a therapist is much like chatting to a friend; dependence 
on the therapist; therapeutic advice similar to what a medical doctor does; and 
immediate therapeutic progress. Two items were added and reformulated into 
expectations dealing with resistance to change (see ABPQ; Furham and Wardley, 
1990) and expectations of the therapist finding solutions for all anxiety-related 
problems. Internal consistency for the TAPS has been calculated at .87 to .92 
(Kushner and Sher, 1989), for the RPQ at .70 (Furham et al., 1992) and for the original 
PQ at .85 (Zwick and Attkisson, 1985). The current study estimated the Cronbach 
alpha for the Process Expectations Questionnaire (PEQ) at .72 (Katerelos, Bélanger et 
al., 1998). 
 
Control Variable. The Anxiety Sensitivity Index (ASI; Reiss et al., 1986) is a 16-item 
questionnaire, rated on a 5-point Likert-type scale, that measures fear of anxiety and 
has been specifically associated with agoraphobia (see Taylor, 1993). Each item 
assesses concerns about the possible negative consequences of symptoms 
associated with anxiety. The internal consistency of the questionnaire has been 
estimated at .88 (Cox et al., 1996) and a two-week test-retest reliability has been 
computed at .75 (Reiss et al., 1986). Psychometric properties of the French-Canadian 
version have been found to be similar to those of the English version (Marchand et 
al., 1999). Internal consistency for the French translation of the ASI was calculated at 
.82 in this study. 
 
Results 
 
Descriptive statistics for the BDI-II 
 
Scores on the BDI-II were normally distribution with a mean score of 18.99 (SD = 10.94; 
range = 2 - 46). A one-way analysis of variance (ANOVA) revealed a significant 
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difference in severity of depressive symptoms in patients suffering from one Axis I 
disorder (n = 49; M = 17.15, SD = 11.02) versus two or more secondary Axis I anxiety 
and affective disorders (n = 27, M = 22.34, SD = 10.14) F(1, 74) = 4.07, p < .05. Those 
with two or more Axis I disorders displayed higher levels of depression. No significant 
relationship was detected between depressive symptoms and duration of PDA (r = 
.08, p > .05) and depressive symptoms and number of panic attacks in the past week 
(r =.05, p > .05).  
 
Predictors of depressive symptoms in PDA 
 
Table 1 presents the means and standard deviations for all expectancy and 
symptom measures, and the correlation between these measures and the BDI-II. All 
measures were distributed normally. 
 
Table 1: Overall distribution of expectancy measures and correlations with the BDI-II 
 
Variables 
 
r with BDI-II 
 
M 
 
SD 
 
Range 
 
Symptom 
 
BSQ 
 
.21       
 
50.39 
 
14.29 
 
17-85 
 
ACQ 
 
.29*     
 
36.76 
 
8.85 
 
17-60 
 
MIA-A 
 
.13       
 
84.38 
 
22.58 
 
42-130 
 
BAI 
 
.25*     
 
28.79 
 
14.43 
 
0-60 
 
Expectancies 
 
ASI 
 
.38*** 
 
35.39 
 
10.55 
 
11-59 
 
SEQ 1 
 
-.38*** 
 
42.08 
 
6.12 
 
28-54 
 
EMIA-A 
 
.33**  
 
54.93 
 
18.76 
 
26-114 
 
PEQ 2 
 
-.40*** 
 
86.24 
 
6.99 
 
69-105 
n = 76.  *p < .05, **p < .01, ***p< .001.  
1 Higher scores: clients expect their panic symptoms to diminish after treatment has ended 
2 Higher scores: greater congruence with treatment process and procedures and therapist and 
participant roles 
                                                 
 
 
  
Europe’s Journal of Psychology 
 
 
251 
Hierarchical regression analyses were conducted to examine whether expectancies 
predicted depressive symptoms in patients suffering from panic disorder with 
agoraphobia, beyond the effects of PDA symptomatology. Analyses were 
conducted into four steps: (1) Since comorbidity main effects were detected, 
comorbidity (i.e., presence or absence) was entered into the first step as a control 
variable. (2) Similarly, because previous data has demonstrated the ASI as a 
predictor of depressive symptoms, it was entered into the second step. (3) Symptom 
measures were entered into the third step in order to ascertain their incremental 
validity. (4) Finally, expectancy measures were entered in the fourth step to 
determine the extent to which these measures add to the prediction rating above 
and beyond the effects of the other measures. Table 2 shows that the ASI added to 
the prediction model of depressive symptoms in PDA above and beyond that of our 
control variable. In fact, when the ASI was included in the prediction model, 
comorbidity failed to enter significantly into the second step. Moreover, the addition 
of PDA symptom measures did not produce significant increments in the explained 
variance over that accounted for by the ASI and comorbidity. However, the 
expectancy measures significantly added to the prediction model of depressive 
symptoms in PDA. These findings suggest that expectancies are better predictors of 
depressive symptoms in PDA then measures commonly used to evaluate PDA 
symptomatology. 
 
Table 2:  Hierarchical Regression Analysis of the BDI-II on PDA Symptomatology and 
Expectancy when Comorbidity and Anxiety Sensitivity are Controlled 
 
Model 
 
Predictor Variables 
 
R2 change 
 
F value for 
R2 change 
 
dfs 
 
Semi-
partial R2 
 
1 
 
Comorbidity 
 
.16** 
 
6.77 
 
2, 73 
 
1.2 
 
 
 
ASI 
 
 
 
 
 
 
 
10.4** 
 
2 
 
ACQ 
 
.01 
 
.54 
 
2, 71 
 
.06 
 
 
 
BAI 
 
 
 
 
 
 
 
1.5 
 
3 
 
PEQ 
 
.16** 
 
5.54 
 
3, 68 
 
6.8* 
 
 
 
SEQ 
 
 
 
 
 
 
 
4.7* 
 
 
 
EMIA-A 
 
 
 
 
 
 
 
.08 
n = 76.  *p < .05, **p < .01, ***p< .001 
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Hierarchical regression analyses were re-ran in order to determine whether process 
expectations (PEQ) and prognostic expectations (SEQ) would significantly predict 
depressive symptoms after controlling for comorbidity and anxiety sensitivity. 
Comorbidity was entered into the first step followed by the ASI and then the PEQ 
and SEQ were entered into the final step. This analysis indicated that 5.2% of the 
variance in the BDI was explained by comorbidity F(1, 74) = 4.07, p < .05, 10.4% of the 
variance was accounted for by the ASI F(1, 73) = 9.02, p < .01, and 16.4% of the 
variance was explained by the PEQ and SEQ F(2, 71) = 8.55, p < .001 accounting for 
a total of 32.0% of the variance. These findings suggest that the inclusion of process 
and prognostic expectancies contribute additional information in predicting 
depressive symptoms in PDA. 
 
Discussion 
 
The current study examined the differential effect of PDA symptomatology and 
expectancies on depressive symptoms above and beyond the influence of 
secondary Axis I disorders (i.e., anxiety and affective disorders) and anxiety 
sensitivity. As hypothesized, expectancies predicted depressive symptoms above 
and beyond the influence of PDA symptomatology, comorbidity and anxiety 
sensitivity. Moreover, symptom measures failed to enter significantly into the model. 
This finding suggests that depressive symptoms in PDA, evaluated prior to any 
therapy, are generally predicted by two or more Axis I disorders, levels of anxiety 
sensitivity, prognostic expectations and expectations related to the procedures in 
therapy.  
 
Our findings showed that individuals with high anxiety sensitivity (i.e., expectations 
about the potential harmfulness of anxiety-related sensations) were more likely to 
experience depressive symptoms. These findings are consistent with previous studies 
examining the links between anxiety sensitivity and depression (Cox et al., 2001; Otto 
et al., 1995; Schmidt et al., 1998; Taylor et al., 1996). These studies detected elevated 
scores on the ASI in depression with no comorbid anxiety disorders (Cox et al., 2001; 
Otto et al., 1995; Schmidt et al., 1998; Taylor et al., 1996). Our data suggest that PDA 
participants with greater fears of their sensations of anxiety, regardless of whether 
they have another comorbid Axis I disorder, will experience greater depressive 
symptoms. The current results may have important implications when planning 
treatment since increased anxiety sensitivity has been previously detected as a 
negative predictor of response to CBT and pharmacotherapy in panic disorder 
(Clark et al., 1994). Since PDA patients with increased depressive symptoms also 
have greater anxiety sensitivity it may be suggested that the addition of depressive 
symptoms may contribute to a poorer treatment outcome. 
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Participants with greater depressive symptoms were also more likely to have low 
expectations that their symptoms of panic would improve following therapy. 
Consistent with Seligman's helplessness theory (Seligman, 1975), it may be suggested 
that expectations of those with depressive symptoms may be more negative due to 
their pessimistic explanatory style. Depressed individuals do not only internalize and 
generalize bad events that happen to them, they also tend to believe that these 
events will remain stable throughout time (see Abramson et al., 1978; Burns and 
Seligman, 1991).  For instance, they may expect that their panic attacks will persist 
even after a treatment has been administered. Moreover, their pessimistic 
explanatory style may contribute to their low expectations of beneficial treatment 
effects. Our results are similar to those of Cohen and colleagues (2001) who 
examined whether "treatment-specific optimism" (e.g., beliefs about the treatment 
working) in cancer patients is associated with better mental health at the beginning 
and at the end of a cancer treatment. They found that patients who had negative 
expectations regarding their treatment outcome were more likely to have a 
depressed mood at the beginning and at the end of treatment. They concluded 
that patients who are not optimistic about the treatment helping them are more 
likely to have depressive symptoms. These findings may have serious implications 
since pessimistic expectations regarding treatment outcome may deter PDA 
patients from participating in therapy if they expect a poor prognosis. Future 
research should examine the effect of cognitive explanatory styles of PDA patients 
with depressive symptoms. 
 
Panic disorder with agoraphobia participants whose expectations of the process 
and procedures of therapy that were congruent with the actual treatment being 
offered demonstrated lower levels of depressive symptoms. Clients with PDA who 
demonstrated positive expectancies in terms of their own role in therapy (e.g., 
participation) and that of the therapist (e.g., expertness of the clinician) also had low 
depressive symptoms. Low depressive PDA patients may have a more optimistic 
cognitive-style that positively affects both their expectations of the therapist 
competency to help them and their expectancy of their personal involvement in the 
therapy.  Depressive symptoms are frequently characterized by low motivation (e.g., 
inability to perform tasks), negative self-concept (e.g., views self as defective or 
inadequate), passivity and inactivity (Beck, Rush, Shaw & Emery, 1979). The above 
variables may have influenced the manner in which PDA patients with high 
depressive symptoms expected to behave in therapy. 
 
The current study demonstrated that PDA patients with relatively high depressive 
symptoms have more overall negative expectations than those with lower 
depression. Regardless of the severity in PDA symptomatology, cognitions related to 
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negative expectancies appeared to be the primary determinants of depressive 
symptoms in PDA.  However, the data are preliminary in nature and most 
expectancy measures that were utilized were new. Future studies should attempt to 
replicate these findings. The psychometric properties of the Process Expectations 
Questionnaire and the Symptom Expectations Questionnaire should undergo further 
study. Future studies should also examine the extent to which optimistic and 
pessimistic cognitive styles are linked to the different types of expectations. In 
addition, their influence on treatment outcome for PDA with depressive symptoms 
should be further explored since negative cognitive styles in high depressive PDA 
patients may interfere with a cognitive-behavioral treatment geared for PDA without 
depression. Finally, although there Eis a greater relationship between negative 
expectations and depressive symptoms in PDA, regression analyses do not allow us 
to conclude that expectations explain the  variance in depression. On the contrary, 
it is possible that depressive symptoms in PDA contribute to negative expectancies.  
 
There may be important implications for treatment process and outcome in patients 
suffering from PDA with depression. Cognitive-behavior therapy appears to be the 
most commonly used and effective psychotherapy for PDA patients. In fact, efficacy 
rates have been reported as high as 80 to 90% (see Margraf et al., 1993). Other, 
findings, nevertheless, show that many panic disorder patients still experience 
substantial anxiety (Klosko et al., 1990) and approximately half of the patients 
experience a reoccurrence of panic attacks two years after CBT (Brown and Barlow, 
1995). Expectancies and depressive symptoms may be factors to consider when the 
effectiveness of CBT is examined.  
 
These findings may suggest that CBT is not effective for some PDA patients.  Perhaps, 
PDA patients with depression may benefit less from CBT if their expectations are not 
addressed at the outset of therapy. Addressing expectations early on in treatment 
may decrease anxiety about undergoing therapy and improve treatment efficacy. 
The treatment may be appropriately tailored to deal with specific expectations (i.e., 
anxiety expectancy, anxiety sensitivity, and process expectations) of those with PDA 
and depressive symptoms. By addressing the negative cognitive styles, including 
their expectations, early on in therapy there may be positive or congruent shifts in 
the different types of expectations from pretherapy to the early-stages of treatment. 
Such cognitive shifts may prove to be important for the long-term outcome of panic 
disorder with agoraphobia. 
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